A detailed history of Manufacturers Life Insurance Company, The transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 295,365 shares of PACB stock, worth $570,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
295,365
Previous 329,815 10.45%
Holding current value
$570,054
Previous $451,000 11.31%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $41,340 - $74,756
-34,450 Reduced 10.45%
295,365 $502,000
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $21,171 - $56,819
15,567 Added 4.95%
329,815 $451,000
Q1 2024

May 14, 2024

SELL
$3.52 - $9.59 $43,046 - $117,276
-12,229 Reduced 3.75%
314,248 $1.18 Million
Q4 2023

Feb 13, 2024

SELL
$5.97 - $10.36 $33,246 - $57,694
-5,569 Reduced 1.68%
326,477 $3.2 Million
Q3 2023

Nov 15, 2023

BUY
$8.23 - $13.93 $401,130 - $678,948
48,740 Added 17.2%
332,046 $2.77 Million
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $298,870 - $421,176
29,977 Added 11.83%
283,306 $3.77 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $159,173 - $240,964
20,047 Added 7.91%
273,376 $3.17 Million
Q4 2022

Aug 11, 2023

SELL
$5.67 - $11.2 $3,549 - $7,011
-626 Reduced 0.25%
253,329 $2.07 Million
Q4 2022

Feb 13, 2023

SELL
$5.67 - $11.2 $3,549 - $7,011
-626 Reduced 0.25%
253,329 $2.07 Million
Q3 2022

Aug 11, 2023

SELL
$3.93 - $8.57 $11,385 - $24,827
-2,897 Reduced 1.13%
253,955 $1.48 Million
Q3 2022

Nov 03, 2022

SELL
$3.93 - $8.57 $11,385 - $24,827
-2,897 Reduced 1.13%
253,955 $1.44 Million
Q2 2022

Aug 11, 2023

BUY
$4.02 - $10.43 $43,054 - $111,705
10,710 Added 4.35%
256,852 $1.14 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $43,054 - $111,705
10,710 Added 4.35%
256,852 $1.16 Million
Q1 2022

Aug 11, 2023

SELL
$8.43 - $20.9 $229,582 - $569,190
-27,234 Reduced 9.96%
246,142 $2.24 Million
Q1 2022

May 20, 2022

BUY
$8.43 - $20.9 $1.25 Million - $3.09 Million
147,698 Added 150.03%
246,142 $2.33 Million
Q4 2021

Feb 16, 2022

SELL
$19.26 - $30.08 $4,892 - $7,640
-254 Reduced 0.26%
98,444 $2.04 Million
Q3 2021

Nov 12, 2021

SELL
$24.86 - $35.02 $239,053 - $336,752
-9,616 Reduced 8.88%
98,698 $2.52 Million
Q2 2021

Aug 12, 2021

BUY
$22.3 - $36.02 $150,502 - $243,098
6,749 Added 6.65%
108,314 $3.79 Million
Q1 2021

May 03, 2021

SELL
$26.38 - $51.15 $86,051 - $166,851
-3,262 Reduced 3.11%
101,565 $3.38 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $106,564 - $289,246
10,149 Added 10.72%
104,827 $2.72 Million
Q3 2020

Nov 09, 2020

BUY
$3.61 - $9.87 $22,714 - $62,102
6,292 Added 7.12%
94,678 $934,000
Q2 2020

Aug 10, 2020

SELL
$2.65 - $4.03 $10,650 - $16,196
-4,019 Reduced 4.35%
88,386 $305,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $15,179 - $33,832
6,432 Added 7.48%
92,405 $283,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $10,041 - $12,159
-2,183 Reduced 2.48%
85,973 $442,000
Q3 2019

Nov 12, 2019

SELL
$4.99 - $6.16 $693 - $856
-139 Reduced 0.16%
88,156 $460,000
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $9,685 - $12,122
-1,636 Reduced 1.82%
88,295 $534,000
Q1 2019

May 13, 2019

BUY
$6.8 - $7.4 $62,056 - $67,532
9,126 Added 11.29%
89,931 $650,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $5,434 - $10,650
-1,362 Reduced 1.66%
80,805 $598,000
Q3 2018

Nov 14, 2018

SELL
$3.52 - $5.55 $46,372 - $73,115
-13,174 Reduced 13.82%
82,167 $445,000
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $7,211 - $13,398
3,418 Added 3.72%
95,341 $338,000
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $15,873 - $25,009
7,743 Added 9.2%
91,923 $189,000
Q4 2017

Feb 08, 2018

BUY
$2.59 - $5.44 $5,560 - $11,679
2,147 Added 2.62%
84,180 $223,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $262,505 - $456,923
82,033
82,033 $431,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.